Research and Clinical Trials

Many of the diagnostic tools and treatments routinely used to care for rheumatic disorders today have been developed or refined by Mount Sinai rheumatologists. For example, Mount Sinai has developed into a major referral center for autoimmune disorders, such as vasculitis, scleroderma, and Sjogren's syndrome.

Today, in addition to providing proven therapies, the Division of Rheumatology is conducting research to advance treatment options, which enables us to offer patients access to emerging therapies via clinical trial enrollments. We are currently conducting ongoing studies in areas that include gout and amyloid diseases.

The observations we make while treating patients are shaped into questions that are then tested through our research. Outcomes from our research then guide the individualized care we provide to every patient. Results from our investigations are shared with physicians worldwide through publication in peer-reviewed medical journals.